Tag: acute respiratory distress syndrome

LOCO2 Trial Summary: Oxygen Therapy in ARDS

2020 2020 LOCO2 TRIAL M Liberal or conservative oxygen therapy for Acute Respiratory Distress Syndrome Multicentre, randomised controlled trial Objective: To assess whether in patients with Acute Respiratory Distress Syndrome (ARDS), does conservative (Target PaO2:55-70mmHg; SpO2: 88-92%) vs. liberal (Target PaO2:90-105mmHg; SpO2: 96%) oxygen reduce death at 28 days 201 patients Adults who were intubated […]